alzheimer-disease

Documents about alzheimer-disease

• New perspectives on VEGF signalling in Alzheimer's disease.#422805NCBI PubMed Central
• AD-GPT: large language models in Alzheimer's disease.#433925NCBI PubMed Central
• Candesartan's Effects on Alzheimer's Disease And Related Biomarkers#435804ClinicalTrials.gov
• APOE-ε4 genotype and western diet synergistically aggravate synaptic dysfunction in Alzheimer’s disease via d-serine disruption#7844HAL (France)
• Developing an AI-Based Visual Decision Support System: A Patient-Centered Perspective for Early Neurological Disease Detection and Prevention – Insights from Alzheimer's Disease and Related Dementia#11947DataCite
• Developing an AI-Based Visual Decision Support System: A Patient-Centered Perspective for Early Neurological Disease Detection and Prevention – Insights from Alzheimer's Disease and Related Dementia#11948DataCite
• Plain language summary: the evoke(+) studies of semaglutide for early Alzheimer’s disease#205386Figshare
• Circulating sphingomyelins correlate with plasma T-tau in cognitively unimpaired older adults at risk of developing Alzheimer's disease#320845Research Online
• Multicenter study on the effect of CPAP on cognitive function in patients with mild cognitive impairment and Alzheimer’s disease with OSA (DemCPAP): presentation of the protocol and preliminary data#482805IRIS
• Recent Insights Into Alzheimer's Disease: Advances in Pathophysiology and Therapeutic Strategies#161229HAL (France)
• Enhancing brain delivery of tegaserod for Alzheimer’s disease: a pharmaceutical comparison of two nanocarrier-based strategies#388152HAL (France)
• The contribution of a high-fat diet to neurodegeneration and oxidative stress in a drosophila melanogaster model of Alzheimer’s disease#483925University of Nottingham Repository
• Worry and Anxiety in the Era of Early Diagnosis and Disease Modifying Treatment for Alzheimer's Disease.#409200NCBI PubMed Central
• Entre el silenci dels records: recerca d’una memòria perduda. Nous enfocaments terapèutics en la malaltia de l’Alzheimer#185002Dipòsit Digital de la Universitat de Barcelona
• Tau Pathology in Alzheimer's Disease Uniquely Affects Sulcal Depths.#123059NCBI PubMed Central
• Cost-Effectiveness of Donanemab for Early Alzheimer Disease in Australia.#125260NCBI PubMed Central
• A brain-penetrant P2X7R antagonist mitigates Alzheimer's disease pathology#162286bioRxiv / medRxiv
• Minor neuropsychological deficits and stage 2 of Alzheimer's disease.#185795NCBI PubMed Central
• Path integration in Alzheimer’s disease: orientation, movement and theta rhythmicity#196163PMC Full-Text (OAI)
• Continuum of Core 1 biomarkers in preclinical Alzheimer's disease.#242159NCBI PubMed Central
• Tau PET Outcomes With Anti-amyloid Immunotherapies#279501ClinicalTrials.gov
• Cardiovascular risk and hippocampal-cognitive coupling in Alzheimer's disease#332446bioRxiv / medRxiv
• Advances in the treatment of Alzheimer's disease.#334841NCBI PubMed Central
• Multimodal neuroimaging approach for cognitive impairment in Alzheimer disease#341970bioRxiv / medRxiv
• Detecting Anosognosia from the Prodromal Stage of Alzheimer’s Disease#360073HAL (France)
• Data-Driven Stochastic Model for Detecting Patientswith Alzheimer's Disease#363407bioRxiv / medRxiv
• Hunting for an Antigen: Humoral Immunity in Alzheimer's Disease.#367984NCBI PubMed Central
• Human Microglial Molecular Alterations in Aging and Alzheimer's Disease.#367989NCBI PubMed Central
• APOE4 Drives Uniquely Dysfunctional Human Microglial States in Alzheimer's Disease#379836bioRxiv / medRxiv
• Mapping Alzheimer's disease heterogeneity through exploratory unsupervised learning.#418313NCBI PubMed Central
• MALDI mass spectrometry imaging (MSI) reveals molecular and structural heterogeneity of amyloid-β in sporadic Alzheimer's disease and Down syndrome#5545Europe PMC
• Defying syntactic preservation in Alzheimer's disease: What type of impairment predicts syntactic change in dementia (if it does) and why?#377723Gestión del Repositorio Documental de la Universidad de Salamanca
• Amyloid-related imaging abnormalities (ARIA) in anti-amyloid therapies for Alzheimer's disease: An update from the Alzheimer's Association ARIA workgroup.#125278NCBI PubMed Central
• The unfolded protein response transcription factor XBP1s ameliorates Alzheimer’s disease by improving synaptic function and proteostasis#276425Repositorio de datos de investigación de la Universidad de Chile Dataverse OAI Archive
• Predictive value of the Alzheimer polygenic risk score on cognitive decline in patients with mild cognitive impairment and Alzheimer's disease dementia.#480974NCBI PubMed Central
• Prosodia rítmico-frecuencial en lingüística clínica: en búsqueda de biomarcadores fonéticos para Alzheimer y Depresión Mayor#475825Gestión del Repositorio Documental de la Universidad de Salamanca
• HIF-1α downregulates the APP protein after oxygen and glucose deprivation in the APPswe/PSEN1 mouse model of Alzheimer’s disease#205302e-cienciaDatos Dataverse OAI Archive
• Gut microbiome composition, metabolic activity, and dietary associations in preclinical Alzheimer’s disease#336317Research Online
• Neuronutrition for the Primary Prevention of Alzheimer’s Disease for Women in Perimenopause and Early Menopause#173146Harvard DASH
• Mild cognitive impairment-to-Alzheimer's dementia progression risk: the contribution of the Interceptor project#5492Europe PMC
• Provider and patient perspectives on the diagnosis and treatment of Alzheimer's disease: A global perspective from the Global Alzheimer's Leadership Series (GoALS).#284876NCBI PubMed Central
• Devinime ilişkin kortikal potansiyellerin hafif bilişsel bozukluk ve orta evre alzheimer hastalığını değerlendirmede nöropsikoljik testler ile korelasyonu#458514Necmettin Erbakan University Institutional Repository
• Spatial proteomics of Alzheimer's disease-specific human microglial states.#9213NCBI PubMed Central
• The Role of Verbal Memory in Masking Symptoms of Alzheimer's Disease#13909bioRxiv / medRxiv
• Midlife sleep characteristics and Alzheimer's disease biomarkers 20 years later.#14806NCBI PubMed Central
• A Multidomain Intervention Program for Older People With Dementia#18821ClinicalTrials.gov
• Restoring Theta–Gamma coupling in Alzheimer's disease: Toward network-based neuromodulation.#30688NCBI PubMed Central
• Tau Pathology in Alzheimer's Disease Uniquely Affects Sulcal Depths#123231Europe PMC
• Idiotypic-susceptible Alzheimer's disease: a clinically relevant, neurofibrillary tangle subtype.#152129NCBI PubMed Central
• PINK1-dependent NFKB signaling contributes to amyloid pathology in Alzheimer disease.#152144NCBI PubMed Central